Apollo Hospitals Enterprise Limited · NSE:APOLLOHOSP

Apollo Hospitals Enterprise — Q3 FY25 Earnings Presentation

42 slides from Apollo Hospitals Enterprise's earnings presentation, Feb 10, 2025

  1. Slide 1: Apollo Hospitals Enterprise Limited stock exchange disclosure letter

    APOLLO HOSPITALS ENTERPRISE LIMITED CIN: L85110TN1979PLC008035 •· A~o110 ~OSPITALS lQth February 2025 The Secretary, The Secretary, Bombay Stock Exchange Ltd (BSE) National Stock Exchange, Phiroze Jheejheebhoy Towers, Exchange Plaza, 5th Floor Dalal Street, Plot No.C/1, 'G' Block Mumbai - 400 001. B

  2. Slide 2: Apollo Hospitals Enterprise Limited Earnings Update Q3 FY25

    Apollo Hospitals Enterprise Limited • Earnings Update Q3 FY25

  3. Slide 3: Disclaimer

    Disclaimer The information contained in this presentation is provided by Apollo Hospitals Enterprise Limited (the “Company”) to you solely for your reference. This document is being given solely for your information and for your use and may not be retained by you and neither this presentation nor an

  4. Slide 4: Content

    Content Financial Performance Snapshot & Business Digital Health Segment wise Update & Pharmacy Distribution 4-9 (Apollo HealthCo) Consolidated Financials 11-12 Healthcare Services 14-23 Diagnostics & Retail Health (AHLL) 25-28 Digital Health & Pharmacy Distribution (Apollo HealthCo) 30-37 Annexure

  5. Slide 5: Financial Performance Snapshot Q3FY25

    Financial Performance Snapshot Q3FY25 Growth Growth Growth (in ₹ Mio) Revenue YoY(%) EBITDA(Post Ind AS) Margin YoY(%) PAT YoY(%) 14% Healthcare Services 24.1% 21% 27,850 13% 6,706 3,483 12.5% Offline PD ^ 20,786 14% 1,593 7.7% 19% Apollo HealthCo Online PD^ & 2,737 22% (1,027) Vs (1,322) in Q3F24 2

  6. Slide 6: Financial Performance Snapshot YTD Dec24

    Financial Performance Snapshot YTD Dec24 Growth Growth Growth (in ₹ Mio) Revenue YoY(%) EBITDA(Post Ind AS) Margin YoY(%) PAT YoY(%) Healthcare Services 83,255 14% 20,144 24.2% 14% 10,409 12.5% 20% Offline PD ^ 59,299 15% 4,509 7.6% 16% Apollo HealthCo Online PD^ & (3,196) 7,868 19% Vs (4,828) in YT

  7. Slide 7: Largest Pan India Hospital Chain

    Largest Pan India Hospital Chain (•) Capacity Operational Hospitals Census Beds1 Census Beds Overall Total 73 10,169 9,429 Delhi: 5 Amritsar: 1 Noida: 1 Owned Hospitals 45 8,736 7,996 Bilaspur: 1 Kanpur: 1 Lucknow: 1 Indirapuram: 1 Managed Hospitals 6 790 790 Jaipur: 1 Day Surgery & 22 643 643 Cradl

  8. Slide 8: AHLL: Transforming Retail Health through access and convenience

    AHLL: Transforming Retail Health through access and convenience Apollo Health & Lifestyle Ltd Out-of-Hospital care • Outpatient Clinics • Diagnostics • Day Surgery centers • Single Specialty Facilities :- Dialysis, Sugar and Dental ~y Apollo Health and Lifestyle Ltd Organizing the unorganized • Path

  9. Slide 9: India's Largest Omni-channel Healthcare Platform

    AHL| India’s Largest Omni-channel Healthcare Platform Apollo HealthCo Ltd • I • Apollo 24|7 Apollo Telehealth* Offline Pharmacy Distribution 1,\ hi Manish • Alw.1.ys c.aung:about your hc;rillh, we eee hc,o to halp ),-ou! Unmatched Size • Provides comprehensive remote healthcare services. • India’s l

  10. Slide 10: Clinical Updates and New Initiatives

    Clinical Updates and New Initiatives • At Apollo Chennai, over 500 robotic cardiac surgeries were successfully performed from June 2019 to October 2024, highest number for a single center in India • At Apollo Bangalore, A robotic knee replacement surgery was successfully performed on a 17-year-old b

  11. Slide 11: Consolidated Financials

    • Consolidated Financials Consolidated Financials © 2024 Apollo Hospitals Enterprise Ltd, All Rights Reserved 10

  12. Slide 12: Consolidated Financials Q3FY25

    Consolidated Financials Q3FY25 (` mio) Digital Health Healthcare Diagnostics & Overall Consolidated Revenue grew by 14% to ` 55,269 mio. ` Mio & Pharmacy Consol Services Retail Health Distribution Total Revenues 27,850 3,895 23,524 55,269 EBITDA grew by 24% to ` 7,615 mio. EBITDA (Pre 24|7 Cost) 6,7

  13. Slide 13: Consolidated Financials YTD Dec24

    Consolidated Financials YTD Dec24 (` mio) Digital Health Overall Consolidated Revenue grew by 15% to ` 162,018 mio. Healthcare Diagnostics & ` Mio & Pharmacy Consol Services Retail Health EBITDA grew by 29% to ` 22,521 mio. Distribution Total Revenues 83,255 11,596 67,167 162,018 EBITDA (Pre 24|7 Co

  14. Slide 14: Healthcare Services Hospitals

    • Healthcare Services Hospitals © 2024 Apollo Hospitals Enterprise Ltd, All Rights Reserved 13

  15. Slide 15: Healthcare Services Financials

    Healthcare Services Financials (` mio) YTD YTD ` Mio Q3FY25 Q3FY24 YoY YoY Dec24 Dec23 No of Hospitals 45 45 45 45 Healthcare Services Revenue grew by 13% in Q3FY25 Operating beds 7,996 7,911 1% 7,996 7,911 1% (Inpatient Volume grew by 5% ; Price & case mix of 8%) Occupancy 68% 66% 69% 65% IP Discha

  16. Slide 16: Inpatients Revenue Mix YTD Dec24

    Inpatients Revenue Mix YTD Dec24 Paed IPS Transplts Uro PSU & Govt 3% Cardio 3% 6% Nephro 3% 18% 10% 4% Self Pay Obs&Gynac 4% Gen Surg 4% 40% 7% Inpatient Inpatient Others Specialty Mix Payor Mix 17% Onco* 10% Internal Med 10% 44% 6% Gastro 10% Neuro Insurance Ortho * Oncology includes Radiotherapy

  17. Slide 17: Healthcare Services: Operational Snapshot

    Healthcare Services : Operational Snapshot Metros: Chennai, Hyderabad, Bangalore, Mumbai, Kolkata and Delhi YTD Dec 24 Metros Non Metros Non Metros (includes Tier1 & Tier2 cities) Ahmedabad, Bhubaneshwar, Lucknow, Operating Indore, Guwahati, Madurai, Trichy, 4,549 3,447 Nellore,Vizag, Kakinada, Myso

  18. Slide 18: Tamil Nadu Region

    Tamil Nadu Region Metro:- Chennai ; Non Metro:- Madurai, Karur, Karaikudi, Trichy and Nellore Nellore Nellore Chennai Tamil Nadu Region Q3FY25 Q3FY24 YoY YTD Dec24 YTD Dec23 YoY Operating Beds 2,039 2,022 0.8% 2,039 2,022 0.8% Bed Occupancy Rate (%) 64% 66% 64% 63% Trichy Inpatient volume 38,561 38,

  19. Slide 19: AP, Telangana Region

    AP, Telangana Region Metro:- Hyderabad; Non Metro:- Karimnagar, Vizag and Kakinada Vishakhapatnam AP, Telangana Region Q3FY25 Q3FY24 YoY YTD Dec24 YTD Dec23 YoY Operating Beds 1,240 1,270 -2.4% 1,240 1,270 -2.4% Bed Occupancy Rate (%) 66% 57% 68% 57% Kakinada Inpatient volume 22,035 19,099 15.4% 65,

  20. Slide 20: Karnataka Region

    Karnataka Region Metro:- Bangalore; Non Metro:- Mysore Karnataka Region Q3FY25 Q3FY24 YoY YTD Dec24 YTD Dec23 YoY Operating Beds 772 750 2.9% 772 750 2.9% Bed Occupancy Rate (%) 71% 67% 75% 66% Inpatient volume 16,991 16,255 4.5% 53,221 48,222 10.4% Outpatient volume (1) 72,056 51,299 40.5% 204,319

  21. Slide 21: Eastern Region

    Eastern Region Metro:- Kolkata; Non Metro:- Guwahati, Bhubaneshwar, Bilaspur and Rourkela Eastern Region Q3FY25 Q3FY24 YoY YTD Dec24 YTD Dec23 YoY Guwahati Operating Beds 1,867 1,812 3.0% 1,867 1,812 3.0% Bed Occupancy Rate (%) 72% 73% 75% 74% Inpatient volume 32,780 31,187 5.1% 101,156 93,479 8.2%

  22. Slide 22: Western Region

    Western Region Metro:- Navi Mumbai; Non Metro:- Nashik and Ahmedabad Western Region Ahmedabad Q3FY25 Q3FY24 YoY YTD Dec24 YTD Dec23 YoY Operating Beds 876 861 1.7% 876 861 1.7% Bed Occupancy Rate (%) 57% 57% 59% 55% Inpatient volume 13,109 13,344 -1.8% 40,195 37,523 7.1% Nashik (1) Outpatient volume

  23. Slide 23: Northern Region

    Northern Region Metro:- Delhi; Non Metro:- Lucknow and Indore Delhi Northern Region Q3FY25 Q3FY24 YoY YTD Dec24 YTD Dec23 YoY Lucknow Operating Beds 1,202 1,196 0.5% 1,202 1,196 0.5% Bed Occupancy Rate (%) 74% 70% 74% 69% Inpatient volume 27,510 24,990 10.1% 82,042 74,635 9.9% (1) Outpatient volume

  24. Slide 24: Healthcare Services: Expansion Plan

    Healthcare Services: Expansion Plan Balance Total Census Project Cost Location Nature Project Cost Beds Beds (in Crs) (in Crs) Expected commissioning : FY26 Royal Mudhol Pune Hospital Asset Acquisition 400 325 ₹ 630 ₹ 265 Sonarpur, Kolkata Hospital Asset Acquisition 270 220 ₹ 310 ₹ 150 Gachibowli, H

  25. Slide 25: Diagnostics & Retail Health Apollo Health & Lifestyle Ltd

    • Diagnostics & Retail Health Apollo Health & Lifestyle Ltd © 2024 Apollo Hospitals Enterprise Ltd, All Rights Reserved 24

  26. Slide 26: Executive Summary: Primary Care, Diagnostics, Specialty Care

    Executive Summary Primary Care Diagnostics Specialty Care ~.A 'ollo Dialysis Clinics !p~~-~QJ 10nls_ ~llo """"'= """"" ,- Suga; Clinics Apollo DIAGNOSTICS ® '.A Apollo Soectra IHOSPITALS 9 Specialists in Surgery ~lo Cradle &Children's Hospital ltolloFertility  Core revenues of Primary Care grew by

  27. Slide 27: AHLL Financials Q3FY25

    AHLL Financials Q3FY25 (` mio) Corporate / Intra Primary Care Diagnostics Specialty Care AHLL Group Revenue 1,069 1,212 1,724 -110 3,895 AHLL Revenues grew by 15% YoY in Q3’ EBITDA 193 116 183 -150 342 FY25; primarily attributed to maturing Q3FY25 margin (%) 18.1% 9.6% 10.6% - 8.8% network EBIT 123

  28. Slide 28: AHLL Financials YTD Dec24

    AHLL Financials YTD Dec24 (` mio) AHLL Revenues grew by 15% YoY in YTD Dec 24; primarily attributed to maturing Corporate / Intra network Primary Care Diagnostics Specialty Care AHLL Group Revenue 3,127 3,721 5,257 -510 11,596 Diagnostics revenue and EBITDA grew EBITDA 576 407 576 -494 1,065 by 8% a

  29. Slide 29: Diagnostics: Key Parameters

    Diagnostics : Key Parameters Gross Revenue (INR Mn) EBITDA (INR Mn)1 Operational footprint (as of Dec 31, 2024) 14% 13% ~330+ 10% 9% 10% ~330+ Cities Cities presence 1,345 168 181 presence 1,122 1,169 1,164 1,212 112 110 116 1 Q3 FY24 Q4 FY24 Q1 FY25 Q2 FY25 Q3 FY25 Q3 FY24 Q4 FY24 Q1 FY25 Q2 FY25 Q

  30. Slide 30: Digital Health & Pharmacy Distribution Apollo HealthCo

    Digital Health & Pharmacy • Distribution Apollo HealthCo © 2024 Apollo Hospitals Enterprise Ltd, All Rights Reserved 29

  31. Slide 31: India's Largest Omni-Channel Healthcare Platform

    India’s Largest Omni-Channel Healthcare Platform Apollo 247 Digital Platform Apollo Pharmacy Platform 6,360 Stores ~16.4% Omni Private ~38 Mn+ Registrations n hi Manish - Added - YTD 334 label / generics Chandigarh: 5 mix ,r; Book Apollo Doctor Appoinlmc,nl , >) Himachal Pradesh: 6 Closed – YTD 4 -

  32. Slide 32: Apollo HealthCo Financials Q3FY25

    Apollo HealthCo Financials Q3FY25 (` mio) Healthco (Q3’ FY25 vs Q3’ FY24); Online Offline Pharmacy Total o 15% growth in revenue in Q3’ FY25 vs Q3’ FY24 ` Mio Pharmacy Distribution & HealthCo Distribution Apollo 247 o PAT positive in Q3’FY25 (Rs. 321 Mn) vs loss of Rs. 276 Mn in Total Revenues 20,78

  33. Slide 33: Apollo HealthCo Financials YTD Dec24

    Apollo HealthCo Financials YTD Dec24 (` mio) Online Offline Pharmacy Total Healthco (YTD Dec 24 vs YTD Dec23); ` Mio Pharmacy Distribution & HealthCo Distribution o 16% growth in revenue in YTD ’FY25 vs YTD ’FY24 Apollo 247 Total Revenues 59,299 7,868 67,167 o PAT positive in YTD ’FY25 (Rs. 382 Mn)

  34. Slide 34: Apollo HealthCo: Advent Investment - Tranche 1 of INR 1732 crs completed

    Apollo HealthCo : Advent Investment - Tranche 1 of INR 1732 crs completed • Apollo Healthco Limited (“AHL”) to raise equity capital of INR 2,475 Crs (USD 300 Mn) from Advent International (“Advent”)1, one of the largest global private equity investors with an AUM of over USD 94 Bn. Tranche 1 of INR

  35. Slide 35: Synergetic Benefit of the Keimed Merger

    Synergetic Benefit of the Keimed Merger Becoming India’s Leading Healthcare Provider 1 Leading Pharma End-to-end, Patient retention Distributor seamless, omnichannel User satisfaction + business model of pharmacy Cross selling Growing Omni distribution with a Apollo Channel Platform fast-growing dig

  36. Slide 36: Proposed Transaction Structure and Steps (1/2)

    Proposed Transaction Structure and Steps (1/2) Post Advent Tranche 1 Investment Post Advent Tranche 2 Investment Pre-Transaction (T) (T+12 Months) AHEL ESOP AHEL Advent ESOP AHEL Advent ESOP 95% 5*% 83.1% 12.5%1 4.4% 79.0% 16.9% 4.1% 2% 11.2% AHL AHL Keimed AHL Keimed Tranche 1 Tranche 2 • Advent in

  37. Slide 37: Proposed Transaction Structure and Steps (2/2)

    Proposed Transaction Structure and Steps (2/2) Launch of Merger Process Post Merger (T+15 Months) (T+30 Months) Keimed AHEL Promoters Keimed 61.5% AHEL 79.0% Shareholders Other minority Advent ESOP FHPL partners 59.2%** 25.7%# Min Max 16.9% 4.1% 16.1% 11.2% Advent ESOP 11.2%* 12.1%+ 3.0% AHL Keimed

  38. Slide 38: Combined Financials Metrics Snapshot YTD Dec24

    Combined Financials Metrix| Snapshot YTD Dec24 (` mio) FY24 Offline Pharma Online Pharma Combined Combined Distribution Total Healthco Keimed Combined Distribution+247 YTD’FY25 Q3’FY25 Revenue 137,701 59,299 7,868 67,167 96,534 121,318 42,355 EBITDA,Pre 9,614 4,348 1,029 5,377 3,002 8,379 2,953 INDA

  39. Slide 39: Annexure

    • Annexure © 2024 Apollo Hospitals Enterprise Ltd, All Rights Reserved 38

  40. Slide 40: Basis of Consolidation

    Basis of Consolidation AHEL AHEL Standalone Hospitals (100% Ownership) Location Subsidiaries Location Description Ownership Chennai Main Chennai Material Subs ACI - Chennai Chennai Apollo Health Co limited India Digital Omni-Channel Healthcare services Platform 100.00% Tondiarpet - Chennai Chennai A

  41. Slide 41: IND AS 116: Impact on P&L and Balance Sheet YTD Dec24

    IND AS - 116 : Impact on P&L and Balance Sheet –YTD Dec24 AHEL Standalone (post IND AS 116) AHEL Consolidated (post IND AS 116) Balance sheet Profit & Loss Balance sheet Profit & Loss Right of use Asset 12,803 Revenue Right of use Asset 23,896 Revenue as of Other expenses 769 as of Other expenses 1,

  42. Slide 42: Thank you !!

    Thank you !! 41

Apollo Hospitals Enterprise — Q3 FY25 Earnings Presentation on 6ix